Nachrichten

WebSeminar: „The latest advances in drug development and production (ATMP and biologics)"

© AWEX (Wallonia Export-Investment Agency), BioWin and BioM

The webseminar „The latest advances in drug development and production (ATMP and biologics)" organized by AWEX (Wallonia Export-Investment Agency), BioWin and BioM will inform you how two leading regions in Europe (Wallonia and Bavaria) have the ambition to collaborate and bring drug development and production to the next level.

The webseminar is planned to bring stakeholders from Wallonia (Belgium) and Bavaria (Germany) together, with the aim of fostering collaboration in various fields relating to advanced medical therapies. Bavaria's pioneering research and development, coupled with Wallonia's leadership in bioproduction, hold high potential for fostering business relationships that can advance greatly the field of drug development.

With an eye on the upcoming BioEurope partnering conference (the European gathering of life sciences bringing together biotech and pharmaceutical professionals for collaboration and deal-making opportunities), AWEX has taken the initiative of bringing together Wallonia and Bavaria in a presentation and preparation webseminar.

Date & time: Monday, October 9 · 3 - 4pm CEST

Location: Online

Agenda:

3.00 - 3.05 pm    A word of welcome and intoduction,  Laurent Renson - AWEX

3.05 - 3.20 pm   Thriving Bavaria: pioneering research and development, Dr. Max Pöhlmann - BioM

3.20 - 3.35 pm   Inspiring Wallonia : leading the way in bioproduction, Thierry Ferrain - BioWin

3.45 - 3.55 pm   Testimonial from a company (Bavaria) - to be announced

3.35 - 3.45 pm   Testimonial from a company (Wallonia) - to be announced

3.55 - 4.00 pm   Q/A

During forty-five minutes, we will go over the strengths and opportunities presented by each region for your activities. The specialized clusters, BioWin and BioM, will each offer insights into the most recent advances in drug development and production with special emphasis on ATMP therapies and platforms and a focus on applications in oncology and immunotherapy. After these insightful presentations, testimonials from both regions will offer tangible examples through their state-of-the-artsolutions.

Finally, the floor will be open for a Q/A before closing the session, offering you the chance to go into specifics relating to your own goals.

Any company, research center or university active in biotechnology and looking for partners in drug development and production can participate.

More information and registration can be found here.